Search Orphan Drug Designations and Approvals
-
Generic Name: | Rifampin |
---|---|
Date Designated: | 03/07/2023 |
Orphan Designation: | Treatment of Frontotemporal Dementia |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Medilabo RFP, Inc. Sanjo CHOJU building 4F 24 Umeda-cho, Nakagyo-ku, Kyoto 604-8136 Japan The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-